Viking Therapeutics (VKTX) Tops Q4 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform